We also observe a significant reduction in lung metastases of colorectal tumours through intravenous delivery of our BEVir targeting CEA on tumour cells, in combination with oncolytic VV encoding a TCE targeting FAP on CAFs or αCTLA4. This evidence concerns the gene FAP and colorectal neoplasm.